FDA Brief

Warning letters Drugs

FDA warning letter to

Belmont Eyecare LLC

High riskIssued Dec 1, 2023Posted Dec 5, 2023Center for Drug Evaluation and Research | CDER

FDA warned Belmont Eyecare that its website sells unapproved new drug eye drops with treatment claims.

What happened

In October 2023, FDA reviewed Belmont Eyecare’s website and found six eye drop products offered for sale in the United States. The site claimed the drops treat eye infections, dry eye, cataracts, macular degeneration, and other conditions, and FDA determined the products are unapproved new drugs with no approved application.

What FDA found

  1. The website claims the eye drops treat infections, dry eye, cataracts, macular degeneration, and other conditions, so FDA treats them as drugs.

    section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)
  2. The products are not generally recognized as safe and effective for those uses, making them new drugs.

    section 201(p) of the FD&C Act, 21 U.S.C. 321(p)
  3. No FDA-approved application is in effect for any of the six eye drop products.

    section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  4. Offering the products for sale in interstate commerce violates the FD&C Act.

    sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a)

What FDA wants

FDA asks Belmont Eyecare to notify it in writing within 15 working days of steps taken to correct the violations and prevent recurrence, with supporting documents. If correction cannot be completed in that time, the company must explain the delay and give a completion date.

Who should pay attention

  • online sellers of eye drops
  • companies making drug-like claims for eye products
  • retailers and marketplaces listing similar products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk